Skip to content

Assessment of Response to the Conventional Periodontal Treatment Based on the Blood Group Phenotypes.

Investigating the Role of ABO Blood Group in the Response to the Nonsurgical Periodontal Treatment.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03644901
Enrollment
60
Registered
2018-08-23
Start date
2018-01-15
Completion date
2019-03-10
Last updated
2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Brief summary

The aim of this study is to find out if one blood group phenotype is more responsive than the others to the nonsurgical periodontal treatment.

Detailed description

To the best of our knowledge, this is the first (research) randomized clinical trial that assesses how patient respond to the nonsurgical periodontal treatment based on their blood group phenotype.

Interventions

patients will undergo nonsurgical periodontal treatment to reduce the relative attachment level and improve the probing depth. An initial session will be conducted to remove supra gingival plaque and calculus. another appointment is set to perform full moth scalling and root planing.

Sponsors

Damascus University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* systematically healthy. * have at least 20 teeth excluding the third molars. * had not received any periodontal treatment or antibiotic therapy for dental or medical reason 6 month prior to the study. * diagnosed with generalized chronic periodontitis (\>30% of the sites have probing depth ≥4), and a minimum of six teeth with probing depth of 5-6 mm.

Exclusion criteria

* smokers and alcoholics. * pregnancy. * history of a systematic disease such as diabetes, leukemia, epilepsy. * participants who are unable to perform routine oral hygiene. * use of orthodontic appliances. * participants who are unable to perform routine oral hygiene.

Design outcomes

Primary

MeasureTime frameDescription
Change in relative attachment level.measures will be taken at baseline and after two months from treatment.the relative attachment level measures the length form the base of the periodontal pocket to a stent

Secondary

MeasureTime frameDescription
Change in periodontal probing depth.measures will be taken at baseline and after two months from treatment.the distance between the gingival margin to the base of the periodontal pocket.
Change in gingival indexindex will be taken at baseline and after two months from treatment.it is used to designate the level of the gingival inflammation.
Change in plaque Indexindex will be taken at baseline and after two months from treatment.it is used to designate the level of plaque accumulation.

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026